Bisphosphonates in Bone Diseases Treatment

被引:1
|
作者
Lazar, Adela Cristina [1 ]
Pacurar, Mariana [2 ]
Campian, Radu Septimiu [1 ]
机构
[1] Iuliu Hatieganu Univ Med & Pharm, Dept Oral Rehabil Oral Hlth & Dent Off Management, 15 Victor Babes, Cluj Napoca 400012, Romania
[2] Univ Med & Pharm, Fac Med Dent, 38 Gh Marinescu Str, Targu Mures 540139, Romania
来源
REVISTA DE CHIMIE | 2017年 / 68卷 / 02期
关键词
bisphosphonates; nitrogen atoms; ATP; osteoporosis; treatment; ZOLEDRONIC ACID; ALENDRONATE; PAMIDRONATE; OSTEOCLAST; RESORPTION; MECHANISMS;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Bisphosphonates are the most frequently used drugs in the treatment of various bone and cancer diseases. They are complex chemical compounds, having a structure similar to that of pyrophosphates, but with certain differences: i.e., bisphosphonates have P-C-P in their composition; instead of an oxygen atom, a carbon atom is present. The R1 and R2 chains bind to the carbon atom and thus, the antiresorptive capacity of bisphosphonates on the one hand, and their bone-binding capacity on the other hand are stimulated. Through their action, they favor the treatment of diseases for which they have been prescribed, but they can also favor a number of undesired side effects.
引用
收藏
页码:246 / 249
页数:4
相关论文
共 50 条
  • [31] Use of bisphosphonates in therapy and prophylaxis of cancer-induced bone diseases
    Sezer, O
    Schmid, P
    Mergenthaler, HG
    Beinert, T
    Possinger, K
    [J]. ONKOLOGIE, 1999, 22 (05): : 400 - 404
  • [32] Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone diseases
    Rosen, CJ
    Kessenich, CR
    [J]. DRUGS, 1996, 51 (04) : 537 - 551
  • [33] Bisphosphonates-much more than only drugs for bone diseases
    Kuznik, Anna
    Pazdzierniok-Holewa, Agnieszka
    Jewula, Pawel
    Kuznik, Nikodem
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 866
  • [34] Pharmacokinetic profile of bisphosphonates in the treatment of metabolic bone disorders
    Sinigaglia, Luigi
    Varenna, Massimo
    Casari, Silvia
    [J]. CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2007, 4 (01) : 30 - 36
  • [35] Bisphosphonates in the treatment of bone metastases in prostate cancer (PCA).
    Voreuther, R
    Heidenreich, A
    Engelmann, UH
    [J]. JOURNAL OF UROLOGY, 1998, 159 (05): : 335 - 335
  • [36] Metastatic bone pain: treatment options with an emphasis on bisphosphonates
    Roger von Moos
    Florian Strasser
    Silke Gillessen
    Kathrin Zaugg
    [J]. Supportive Care in Cancer, 2008, 16 : 1105 - 1115
  • [37] Metastatic bone pain: treatment options with an emphasis on bisphosphonates
    von Moos, Roger
    Strasser, Florian
    Gillessen, Silke
    Zaugg, Kathrin
    [J]. SUPPORTIVE CARE IN CANCER, 2008, 16 (10) : 1105 - 1115
  • [38] Should bisphosphonates be the treatment of choice for metastatic bone disease?
    Coleman, RE
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (04) : 35 - 41
  • [39] Bisphosphonates:: new therapeutic agents for the treatment of bone tumors
    Heymann, D
    Ory, B
    Gouin, F
    Green, JR
    Rédini, F
    [J]. TRENDS IN MOLECULAR MEDICINE, 2004, 10 (07) : 337 - 343
  • [40] BISPHOSPHONATES - A NEW CONCEPT FOR THE TREATMENT OF METABOLIC BONE DISORDERS
    RAUE, F
    GRAUER, A
    [J]. MEDIZINISCHE KLINIK, 1994, 89 (08) : 421 - 428